Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

6.5K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.5K
Tumor Progression02:07

Tumor Progression

7.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.5K
Uterine Tubes01:16

Uterine Tubes

2.8K
The uterine or fallopian tubes function as the conduit through which oocytes travel from the ovaries to the uterus. Each fallopian tube measures approximately 10 to 13 cm long and is anatomically divided into the infundibulum, ampulla, isthmus, and interstitial part (or intramural segment). The infundibulum is characterized by its funnel shape and features extensions called fimbriae which reach towards the peritoneal cavity. These fimbriae play a critical role during ovulation as they extend...
2.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dose Reduction of Preoperative Radiotherapy in Myxoid Liposarcoma: The Phase 2 DOREMY Nonrandomized Clinical Trial.

JAMA oncology·2026
Same author

ESTRO clinical practice guideline on radiotherapy for adult soft tissue sarcoma of the extremities and trunk wall - Endorsed by ASTRO.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026
Same author

Diagnosis and treatment of primary soft tissue sarcomas: comprehensive review.

BJS open·2026
Same author

Management of peripheral-vein leiomyosarcomas, recurrence patterns and individualised treatment strategy.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2025
Same author

A novel risk score after neoadjuvant imatinib predicts relapse-free survival in patients with gastrointestinal stromal tumours (GIST).

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2025
Same author

Efficacy and cardiac safety of aldoxorubicin in metastatic solitary fibrous tumour.

Rare tumors·2025
Same journal

Associations of Gestational Weight Gain Up to 24 Weeks with Pregnancy Outcomes: A Chinese Retrospective Cohort Study.

International journal of women's health·2026
Same journal

"When a Thorn Comes Into Your Body, You Must Remove It". A Socio-Ecological Analysis of the Acceptability of Intravaginal Artesunate as Cervical Precancer Treatment in a Phase 1 Clinical Trial.

International journal of women's health·2026
Same journal

Previous Cerebral Venous Sinus Thrombosis in Pregnancy: Clinical Challenges and Outcomes - A Case Report.

International journal of women's health·2026
Same journal

Temporal Trends in Cancer Burden and 27 Subtypes Among Women of Childbearing Age Globally from 1990 to 2021.

International journal of women's health·2026
Same journal

Genetic Associations Between Premature Ovarian Insufficiency and Bone Health Traits: A Bidirectional Two-Sample Mendelian Randomization Study.

International journal of women's health·2026
Same journal

Epidemiological Characteristics and Genotype Distribution of Human Papillomavirus Among Women of Different Ethnic Groups in the Yili Region: A Retrospective Study of 13,915 Women.

International journal of women's health·2026
See all related articles

Related Experiment Video

Updated: Feb 22, 2026

Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model
13:41

Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model

Published on: January 13, 2023

2.9K

Uterine sarcoma - current perspectives.

Charlotte Benson1, Aisha B Miah1,2

  • 1Sarcoma Unit, Royal Marsden Hospital.

International Journal of Women'S Health
|September 19, 2017
PubMed
Summary
This summary is machine-generated.

Uterine sarcomas are rare cancers often diagnosed post-surgery. Current treatments lack definitive survival benefits, necessitating clinical trials and international collaboration for rare uterine sarcoma subtypes.

Keywords:
endometrial stromal sarcomaleiomyomaleiomyosarcomasarcomaundifferentiated uterine sarcoma

More Related Videos

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas
09:21

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas

Published on: September 13, 2019

7.6K
An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
09:48

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

Published on: September 12, 2019

8.7K

Related Experiment Videos

Last Updated: Feb 22, 2026

Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model
13:41

Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model

Published on: January 13, 2023

2.9K
Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas
09:21

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas

Published on: September 13, 2019

7.6K
An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
09:48

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

Published on: September 12, 2019

8.7K

Area of Science:

  • Gynecologic Oncology
  • Oncology
  • Pathology

Background:

  • Uterine sarcomas are a rare, heterogeneous group of tumors.
  • Preoperative imaging often fails to differentiate benign leiomyomas from malignant uterine sarcomas.
  • Diagnosis is frequently incidental, occurring after surgery for presumed benign conditions.

Purpose of the Study:

  • To review the current understanding of uterine sarcoma diagnosis, treatment, and management.
  • To highlight the challenges posed by the rarity and heterogeneity of these tumors.
  • To emphasize the importance of multidisciplinary care and clinical trials.

Main Methods:

  • Review of existing literature on uterine sarcomas.
  • Analysis of diagnostic challenges and treatment outcomes.
  • Discussion of current and emerging therapeutic strategies.

Main Results:

  • Uterine leiomyosarcoma is the most common subtype, with others including endometrial stromal sarcoma, undifferentiated uterine sarcoma, and adenosarcoma.
  • Adjuvant radiotherapy and chemotherapy have not shown definitive survival benefits in clinical trials.
  • Systemic chemotherapy agents like doxorubicin, trabectedin, gemcitabine, eribulin, and pazopanib show activity in metastatic disease.

Conclusions:

  • Adjuvant treatment may benefit selected cases after multidisciplinary discussion.
  • Systemic chemotherapy is considered for metastatic uterine sarcoma.
  • Clinical trial participation and international collaboration are crucial for advancing research and treatment for rare uterine sarcomas.